About Associacao de Combate ao Cancer em Goias - Hospital de Cancer Araujo Jorge
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Associacao de Combate ao Cancer em Goias - Hospital de Cancer Araujo Jorge
During the past decade, Associacao de Combate ao Cancer em Goias - Hospital de Cancer Araujo Jorge conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
1998-10-01
2016-12-01
Completed
682
Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
2000-10-01
Unknown status
Combination Chemotherapy in Treating Patients With Bladder Cancer
2004-03-01
2009-04-01
Completed
42
ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere
2002-08-01
2005-12-01
Unknown status
250
STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea
2002-12-01
2003-07-01
Completed
150
Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer
2002-05-01
2005-03-01
Completed
612
Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen
2003-09-01
2007-03-01
Completed
Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous Leukemia
2004-08-15
Active, not recruiting
406
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Associacao de Combate ao Cancer em Goias - Hospital de Cancer Araujo Jorge" #1 sponsor was "Janssen Research & Development, LLC" with 4 trials, followed by "Bayer" with 3 trials
sponsored, "AstraZeneca" with 2 trials sponsored, "Brazilian Society of Head and Neck Surgery" with 1 trials sponsored and "Bristol-Myers Squibb"
with 1 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Associacao de Combate ao Cancer em Goias - Hospital de Cancer Araujo Jorge"
#1 collaborator was "Merck Sharp & Dohme LLC" with 3 trials as a collaborator, "Myriad Genetic Laboratories, Inc." with 2 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator, "GOG Foundation" with 1 trials as a collaborator and "Johnson & Johnson" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at Associacao de Combate ao Cancer em Goias - Hospital de Cancer Araujo Jorge
According to Clinical.Site data, the most researched conditions in "Associacao de Combate ao Cancer em Goias - Hospital de Cancer Araujo Jorge" are
"Head and Neck Cancer" (2 trials), "Prostatic Neoplasms" (2 trials), "Advanced Ovarian Cancer" (1 trials), "BRCA Mutated" (1 trials) and "BRCA Mutation" (1 trials). Many other conditions were trialed in "Associacao de Combate ao Cancer em Goias - Hospital de Cancer Araujo Jorge" in a lesser frequency.
Clinical Trials Intervention Types at Associacao de Combate ao Cancer em Goias - Hospital de Cancer Araujo Jorge
Most popular intervention types in "Associacao de Combate ao Cancer em Goias - Hospital de Cancer Araujo Jorge" are "Drug" (14 trials), "Other" (3 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Darolutamide (Nubeqa, BAY1841788)" (2 trials), "Olaparib 300mg tablets" (2 trials), "Placebo" (2 trials), "Abiraterone acetate (AA)" (1 trials) and "Androgen Deprivation Therapy (ADT)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Associacao de Combate ao Cancer em Goias - Hospital de Cancer Araujo Jorge
The vast majority of trials in "Associacao de Combate ao Cancer em Goias - Hospital de Cancer Araujo Jorge" are
9 trials for "All" genders, 4 trials for "Male" genders and 3 trials for "Female" genders.
Clinical Trials Status at Associacao de Combate ao Cancer em Goias - Hospital de Cancer Araujo Jorge
Currently, there are NaN active trials in "Associacao de Combate ao Cancer em Goias - Hospital de Cancer Araujo Jorge".
undefined are not yet recruiting,
6 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Associacao de Combate ao Cancer em Goias - Hospital de Cancer Araujo Jorge,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Associacao de Combate ao Cancer em Goias - Hospital de Cancer Araujo Jorge, 1 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".